{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:47Z","timestamp":1792121147058,"version":"4.4.0"},"reference-count":114,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Type 2 diabetes (T2D) and cardiovascular diseases (CVDs) are major public health challenges worldwide. Metabolomics, the exhaustive assessment of metabolites in biological systems, offers important insights regarding the metabolic disturbances related to these disorders. Recent advances toward the integration of metabolomics into clinical practice to facilitate the discovery of novel biomarkers that can improve the diagnosis, prognosis, and treatment of T2D and CVDs are discussed in this review. Metabolomics offers the potential to characterize the key metabolic alterations associated with disease pathophysiology and treatment. T2D is a heterogeneous disease that develops through diverse pathophysiological processes and molecular mechanisms; therefore, the disease-causing pathways of T2D are not completely understood. Recent studies have identified several robust clusters of T2D variants representing biologically meaningful, distinct pathways, such as the beta cell and proinsulin cluster related to pancreatic insulin secretion, obesity, lipodystrophy, the liver\/lipid cluster, glycemia, and blood pressure, and metabolic syndrome clusters representing different pathways causing insulin resistance. Regarding CVDs, recent studies have allowed the metabolomic profile to delineate pathways that contribute to atherosclerosis and heart failure, as well as to the development of targeted therapy. This review also covers the role of metabolomics in integrated metabolic genomics and other omics platforms to better understand disease mechanisms, along with the transition toward precision medicine. This review further investigates the use of metabolomics in multi-metabolite modeling to enhance risk prediction models for predicting the first occurrence of major adverse cardiovascular events among individuals with T2D, highlighting the value of such approaches in optimizing the preventive and therapeutic models used in clinical practice.<\/jats:p>","DOI":"10.3390\/ijms26083572","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:46:20Z","timestamp":1744274780000},"page":"3572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advances in Metabolomics: A Comprehensive Review of Type 2 Diabetes and Cardiovascular Disease Interactions"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-842X","authenticated-orcid":false,"given":"Lilian","family":"Fernandes Silva","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, Finland"},{"name":"Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-7749","authenticated-orcid":false,"given":"Markku","family":"Laakso","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, Finland"},{"name":"Department of Medicine, Kuopio University Hospital, 70200 Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","article-title":"Metabolomic profiles predict individual multidisease outcomes","volume":"28","author":"Buergel","year":"2022","journal-title":"Nat. Med."},{"key":"ref_2","unstructured":"World Health Organization (2025). Urgent Action Needed as Global Diabetes Cases Increase Four-Fold Over Past Decades, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41467-022-29143-5","article-title":"Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci","volume":"13","author":"Yin","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.ajhg.2022.08.007","article-title":"Integrating transcriptomics, metabolomics, and GWAS helps reveal molecular mechanisms for metabolite levels and disease risk","volume":"109","author":"Yin","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-025-02581-3","article-title":"Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics","volume":"24","author":"Xie","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mora-Ortiz, M., Alcala-Diaz, J.F., Rangel-Zu\u00f1iga, O.A., Larriva, A.P.A.-D., Abollo-Jimenez, F., Luque-Cordoba, D., Priego-Capote, F., Malagon, M.M., Delgado-Lista, J., and Ordovas, J.M. (2022). Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: A CORDIOPREV clinical trial study. BMC Med., 20.","DOI":"10.1186\/s12916-022-02566-z"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Long, J., Yang, Z., Wang, L., Han, Y., Peng, C., Yan, C., and Yan, D. (2020). Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: A systematic review and meta-analysis. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-00653-x"},{"key":"ref_8","first-page":"225","article-title":"Cardiovascular disease in type 2 diabetes: Challenge for treatment and prevention","volume":"249","author":"Laakso","year":"2001","journal-title":"J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Batty, M., Bennett, M.R., and Yu, E. (2022). The role of oxidative stress in atherosclerosis. Cells, 11.","DOI":"10.3390\/cells11233843"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.53941\/ijddp.2024.100019","article-title":"Metabolomics in cardiovascular diseases","volume":"3","author":"Lu","year":"2024","journal-title":"Int. J. Drug Discov. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: Metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/clinem\/dgae422","article-title":"Effects of genetic risk on incident type 2 diabetes and glycemia: The T2D-GENE lifestyle intervention trial","volume":"110","author":"Lankinen","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41579-021-00621-9","article-title":"Mass spectrometry-based metabolomics in microbiome investigation","volume":"20","author":"Bauermeister","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Di Minno, A., Gelzo, M., Caterino, M., Costanzo, M., Ruoppolo, M., and Castaldo, G. (2022). Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095213"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","article-title":"The future of NMR-based metabolomics","volume":"43","author":"Markley","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Geyer, T., R\u00fcbenthaler, J., Alunni-Fabbroni, M., Schinner, R., Weber, S., Mayerle, J., Schiffer, E., H\u00f6ckner, S., Malfertheiner, P., and Ricke, J. (2021). NMR-based lipid metabolite profiles to predict outcomes in patients undergoing interventional therapy for a Hepatocellular Carcinoma (HCC): A substudy of the SORAMIC trial. Cancers, 13.","DOI":"10.3390\/cancers13112787"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Anh, N.K., Thu, N.Q., Tien, N.T.N., Long, N.P., and Nguyen, H.T. (2024). Advancements in mass spectrometry-based targeted metabolomics and lipidomics: Implications for clinical research. Molecules, 29.","DOI":"10.3390\/molecules29245934"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Crook, A.A., and Powers, R. (2020). Quantitative NMR-based biomedical metabolomics: Current status and applications. Molecules, 25.","DOI":"10.3390\/molecules25215128"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","article-title":"The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research","volume":"1277","author":"Emwas","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","article-title":"Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics","volume":"100","author":"Marshall","year":"2017","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Son, A., Kim, W., Park, J., Park, Y., Lee, W., Lee, S., and Kim, H. (2024). Mass spectrometry advancements and applications for biomarker discovery, diagnostic innovations, and personalized medicine. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189880"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Al-Akl, N.S., Khalifa, O., Ponirakis, G., Parray, A., Ramadan, M., Khan, S., Chandran, M., Ayadathil, R., Elsotouhy, A., and Own, A. (2024). Untargeted metabolomic profiling reveals differentially expressed serum metabolites and pathways in Type 2 diabetes patients with and without cognitive decline: A Cross-Sectional Study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042247"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2017.03.027","article-title":"Lipidomics by ultrahigh performance liquid chromatography-high resolution mass spectrometry and its application to complex biological samples","volume":"1053","author":"Triebl","year":"2017","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.csbj.2016.02.005","article-title":"A guide to the identification of metabolites in NMR-based metabonomics\/metabolomics experiments","volume":"14","author":"Dona","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Titkare, N., Chaturvedi, S., Borah, S., and Sharma, N. (2024). Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery. Biomed. Chromatogr., 38.","DOI":"10.1002\/bmc.6019"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-022-01449-0","article-title":"Metabolomics of type 1 and type 2 diabetes: Insights into risk prediction and mechanisms","volume":"22","author":"Izundegui","year":"2022","journal-title":"Curr. Diab. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2337\/dc21-1705","article-title":"Metabolomics and type 2 diabetes risk: An updated systematic review and meta-analysis of prospective cohort studies","volume":"45","author":"Morze","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCRESAHA.120.315898","article-title":"Metabolomics and proteomics in type 2 diabetes","volume":"126","author":"Chen","year":"2020","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Laakso, M., and Fernandes-Silva, L. (2022). Genetics of type 2 diabetes: Past, present, and future. Nutrients, 14.","DOI":"10.3390\/nu14153201"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Arneth, B., Arneth, R., and Shams, M. (2019). Metabolomics of type 1 and type 2 diabetes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102467"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jdi.13970","article-title":"Progress in genetics of type 2 diabetes and diabetic complications","volume":"14","author":"Shojima","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"102971","DOI":"10.1016\/j.eclinm.2024.102971","article-title":"Novel type 2 diabetes prediction score based on traditional risk factors and circulating metabolites: Model derivation and validation in two large cohort studies","volume":"79","author":"Xie","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41746-021-00521-5","article-title":"Digital medicine and the curse of dimensionality","volume":"4","author":"Berisha","year":"2021","journal-title":"NPJ Digit. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/oby.23951","article-title":"Branched chain amino acids and type 2 diabetes: A bidirectional Mendelian randomization analysis","volume":"32","author":"Mosley","year":"2024","journal-title":"Obesity"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lotta, L.A., Scott, R.A., Sharp, S.J., Burgess, S., Luan, J.A., Tillin, T., Schmidt, A.F., Imamura, F., Stewart, I.D., and Perry, J.R. (2016). Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: A Mendelian randomisation analysis. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002179"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1039\/D3AY00778B","article-title":"Serum metabolomic analysis revealed potential metabolite biomarkers for diabetes mellitus with coronary heart disease","volume":"15","author":"Jin","year":"2023","journal-title":"Anal. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.molmet.2019.06.016","article-title":"Biomarkers for Type 2 Diabetes","volume":"27","author":"Laakso","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating metabolites and the risk of Type 2 Diabetes: A prospective study of 11,896 young adults from four Finnish Cohorts","volume":"62","author":"Mustelin","year":"2019","journal-title":"Diabetologia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2337\/dc13-0800","article-title":"Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men","volume":"36","author":"Mahendran","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gu, X., Al Dubayee, M., Alshahrani, A., Masood, A., Benabdelkamel, H., Zahra, M., Li, L., Rahman, A.M.A., and Aljada, A. (2020). Distinctive metabolomics patterns associated with insulin resistance and Type 2 Diabetes Mellitus. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.609806"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yang, S.J., Kwak, S.-Y., Jo, G., Song, T.-J., and Shin, M.-J. (2018). Serum metabolite profile associated with incident Type 2 Diabetes in Koreans: Findings from the Korean genome and epidemiology study. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-26320-9"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yang, K., Li, J., Hui, X., Wang, W., and Liu, Y. (2024). Assessing the causal relationship between metabolic biomarkers and coronary artery disease by Mendelian randomization studies. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-69879-2"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00125-020-05253-x","article-title":"An atlas on risk factors for type 2 diabetes: A wide-angled Mendelian randomisation study","volume":"63","author":"Yuan","year":"2020","journal-title":"Diabetologia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00125-023-05879-7","article-title":"Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: Evidence, opportunities and challenges","volume":"66","author":"Yuan","year":"2023","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db16-0868","article-title":"Systolic blood pressure and risk of type 2 diabetes: A Mendelian randomization study","volume":"66","author":"Aikens","year":"2017","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/db18-1048","article-title":"Liver function and risk of type 2 diabetes: Bidirectional Mendelian randomization study","volume":"68","author":"Borges","year":"2019","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/dc21-1262","article-title":"Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: A Mendelian randomization study","volume":"45","author":"Martin","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wainberg, M., Mahajan, A., Kundaje, A., McCarthy, M.I., Ingelsson, E., Sinnott-Armstrong, N., and Rivas, M.A. (2019). Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study. PLoS Med., 16.","DOI":"10.1371\/journal.pmed.1002982"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Yuan, S., and Larsson, S.C. (2019). A causal relationship between cigarette smoking and type 2 diabetes mellitus: A Mendelian randomization study. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-56014-9"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, X., Tang, J., Lin, S., Liu, X., and Li, Y. (2024). Mendelian randomization analysis demonstrates the causal effects of IGF family members in diabetes. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1332162"},{"key":"ref_54","first-page":"e70012","article-title":"Gut microbiota in health and disease: Advances and future prospects","volume":"5","author":"Zhang","year":"2024","journal-title":"Med. Comm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13668-020-00307-3","article-title":"Metabolites linking the gut microbiome with risk for type 2 diabetes","volume":"2","author":"Zhu","year":"2020","journal-title":"Curr. Nutr. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., and Feng, X. (2025). When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies. Biochem. Pharmacol., 233.","DOI":"10.1016\/j.bcp.2025.116791"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., and Fu, Q. (2025). The role of short-chain fatty acid in metabolic syndrome and its complications: Focusing on immunity and inflammation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1519925"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.micpath.2017.07.034","article-title":"The association of type II diabetes with gut microbiota composition","volume":"110","author":"Sedighi","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Mirzaei, S., DeVon, H.A., Cantor, R.M., Cupido, A.J., Pan, C., Ha, S.M., Silva, L.F., Hilser, J.R., Hartiala, J., and Allayee, H. (2024). Relationships and mendelian randomization of gut microbe-derived metabolites with metabolic syndrome traits in the METSIM Cohort. Metabolites, 14.","DOI":"10.3390\/metabo14030174"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Abildinova, G.Z., Benberin, V.V., Vochshenkova, T.A., Afshar, A., Mussin, N.M., Kaliyev, A.A., Zhussupova, Z., and Tamadon, A. (2024). The gut-brain-metabolic axis: Exploring the role of microbiota in insulin resistance and cognitive function. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1463958"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zheng, X., Chen, M., Zhuang, Y., Zhao, L., Qian, Y., Xu, J., and Fan, J. (2024). Genetic associations between gut microbiota and type 2 diabetes mediated by plasma metabolites: A Mendelian randomization study. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1430675"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.O072629","article-title":"The Metabolic Syndrome in Men study: A resource for studies of metabolic and cardiovascular diseases","volume":"58","author":"Laakso","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/dc19-2533","article-title":"Microbiota-related metabolites and the risk of type 2 diabetes","volume":"43","author":"Vangipurapu","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: Where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Udler, M.S., Kim, J., von Grotthuss, M., Bon\u00e0s-Guarch, S., Cole, J.B., Chiou, J., Anderson, C.D., Boehnke, M., Laakso, M., and Atzmon, G. (2018). Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med., 15.","DOI":"10.1101\/319509"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCRESAHA.120.315890","article-title":"The molecular basis of predicting atherosclerotic cardiovascular disease risk","volume":"128","author":"Nayor","year":"2021","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2022.09.018","article-title":"Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2D and AMI using a liquid chromatography tandem mass spectrometry method","volume":"536","author":"Tang","year":"2022","journal-title":"Clin. Chim. Acta."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Qin, M., Wang, Z., Wu, Y., Chen, X., Liu, C., Ma, Q., Liu, Y., Lai, W., and Chen, H. (2022). Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease. Cell Biosci., 12.","DOI":"10.1186\/s13578-022-00863-x"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Guo, Z., Zhong, Y., Zhou, L., Xu, P., Gao, N., Lu, J., Yan, X., and Cao, H. (2024). Unveiling the microbiota-metabolite-myocardium axis: A novel perspective on cardiovascular health. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1389311"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","article-title":"Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Comm."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ma, Y., Chu, M., Fu, Z., Liu, Q., Liang, J., Xu, J., Weng, Z., Chen, X., Xu, C., and Gu, A. (2023). The association of metabolomic profiles of a healthy lifestyle with heart failure risk in a prospective study. Nutrients, 15.","DOI":"10.3390\/nu15132934"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1253\/circj.CJ-17-1184","article-title":"Metabolomic analysis in heart failure","volume":"82","author":"Ikegami","year":"2017","journal-title":"Circ. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"119103","DOI":"10.1016\/j.atherosclerosis.2024.119103","article-title":"Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank","volume":"401","author":"Gibson","year":"2025","journal-title":"Atherosclerosis"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"119832","DOI":"10.1016\/j.cca.2024.119832","article-title":"Large-scale comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis","volume":"562","author":"Sun","year":"2024","journal-title":"Clin. Chim. Acta."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41065-025-00367-x","article-title":"Lipidomics-based investigation of its impact on the pathogenesis of coronary atherosclerosis: A Mendelian randomization study","volume":"162","author":"Wang","year":"2025","journal-title":"Hereditas"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Wu, Y., Mai, J., Guo, G., Meng, J., Fang, X., Chen, X., Liu, C., and Zhong, S. (2022). Comprehensive metabolic profiling of inflammation indicated key roles of glycerophospholipid and arginine metabolism in coronary artery disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.829425"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1210\/clinem\/dgab562","article-title":"The association of 9 amino acids with cardiovascular events in Finnish men in a 12-year follow-up study","volume":"106","author":"Jauhiainen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/heartjnl-2019-315615","article-title":"Metabolic phenotyping and cardiovascular disease: An overview of evidence from epidemiological settings","volume":"107","author":"Iliou","year":"2021","journal-title":"Heart"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Prechtl, L., Carrard, J., Gallart-Ayala, H., Borreggine, R., Teav, T., K\u00f6nigstein, K., Wagner, J., Knaier, R., Infanger, D., and Streese, L. (2024). Features urea cycle alterations associated with coronary artery disease. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-76835-7"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5551\/jat.42945","article-title":"Identification of metabolites associated with onset of CAD in diabetic patients using CE-MS analysis: A pilot study","volume":"26","author":"Omori","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Vernon, S.T., Tang, O., Kim, T., Chan, A.S., Kott, K.A., Park, J., Hansen, T., Koay, Y.C., Grieve, S.M., and O\u2019sullivan, J.F. (2021). Metabolic signatures in coronary artery disease: Results from the BioHEART-CT Study. Cells., 10.","DOI":"10.3390\/cells10050980"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e004437","DOI":"10.1161\/CIRCGEN.123.004437","article-title":"Circulating metabolite profiles and risk of coronary heart disease among racially and geographically diverse populations","volume":"17","author":"Deng","year":"2024","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yang, S., Feng, G., Zhu, Z., Zhang, T., and Zhang, W. (2025). Metabolites and coronary heart disease: A two sample Mendelian Randomization. Int. J. Cardiol. Cardiovasc. Risk Prev., 200365.","DOI":"10.1016\/j.ijcrp.2025.200365"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e036906","DOI":"10.1161\/JAHA.124.036906","article-title":"Metabonomic biomarkers of plaque burden and instability in patients with coronary atherosclerotic disease after moderate lipid-lowering therapy","volume":"13","author":"Mei","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Anlar, G.G., Anwardeen, N., Al Ashmar, S., Pedersen, S., Elrayess, M.A., and Zeidan, A. (2024). Metabolomics profiling of stages of coronary artery disease progression. Metabolites, 14.","DOI":"10.3390\/metabo14060292"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/CIRCRESAHA.122.321253","article-title":"Gut microbially produced indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol transport and its deficiency is causally related to atherosclerotic cardiovascular disease","volume":"131","author":"Xue","year":"2022","journal-title":"Circ. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Laakso, M., and Fernandes Silva, L. (2023). Statins and risk of type 2 diabetes: Mechanism and clinical implications. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1239335"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41467-020-20750-8","article-title":"An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease","volume":"12","author":"Cohain","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurjpc\/zwad160","article-title":"Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes","volume":"30","author":"Huang","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Costanzo, M., Caterino, M., Sotgiu, G., Ruoppolo, M., Franconi, F., and Campesi, I. (2022). Sex differences in the human metabolome. Biol. Sex. Differ., 13.","DOI":"10.1186\/s13293-022-00440-4"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.121.320134","article-title":"Differences in metabolomic profiles between black and white women and risk of coronary heart disease: An observational study of women from four US cohorts","volume":"131","author":"Hu","year":"2022","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"117147","DOI":"10.1016\/j.atherosclerosis.2023.05.016","article-title":"Sex differences in associations of plasma metabolites with blood pressure and heart rate variability: The HELIUS Study","volume":"384","author":"Verhaar","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.116.023005","article-title":"Sex-based differences in cardiometabolic biomarkers","volume":"135","author":"Lew","year":"2017","journal-title":"Circulation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2222070","DOI":"10.1001\/jamanetworkopen.2022.22070","article-title":"Sex differences in the progression of metabolic risk factors in diabetes development","volume":"5","author":"Yoshida","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11883-020-00864-6","article-title":"The role of sex-specific risk factors in the risk assessment of atherosclerotic cardiovascular disease for primary prevention in women","volume":"22","author":"Freaney","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amepre.2023.05.011","article-title":"Sex differences in cardiovascular risk Associated with prediabetes and undiagnosed diabetes","volume":"65","author":"Yoshida","year":"2023","journal-title":"Am. J. Prev. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/dc24-1412","article-title":"Proteomic and metabolomic signatures in prediabetes progressing to diabetes or reversing to normoglycemia within 1 year","volume":"48","author":"Barovic","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Norman, J.E., Nuthikattu, S., Milenkovic, D., and Villablanca, A.C. (2023). Sex modifies the impact of type 2 diabetes mellitus on the murine whole brain metabolome. Metabolites, 13.","DOI":"10.3390\/metabo13091012"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41467-025-56695-z","article-title":"Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities","volume":"16","author":"Loesch","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00125-017-4442-9","article-title":"Biomarkers of cardiovascular diseases: Contributions to risk prediction in individuals with diabetes","volume":"61","author":"Bachmann","year":"2018","journal-title":"Diabetologia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCRESAHA.123.322590","article-title":"Proteomic Atlas of Atherosclerosis: The contribution of proteoglycans to sex differences, plaque phenotypes, and outcomes","volume":"133","author":"Theofilatos","year":"2023","journal-title":"Circ. Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Lu, Y., Li, G., Viallon, V., Ferrari, P., Freisling, H., Qiao, Y., Shao, L., Wu, L., Ding, Y., and Ke, C. (2024). A large study of metabolomics reveals common and distinct metabolic biomarkers for type 2 diabetes, coronary heart disease, and stroke. Am. J. Epidemiol., kwae167.","DOI":"10.1093\/aje\/kwae167"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12933-023-02102-0","article-title":"Characterizing the metabolic divide: Distinctive metabolites differentiating CAD-T2DM from CAD patients","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4070\/kcj.2023.0048","article-title":"The gut-heart axis: Updated review for the roles of microbiome in cardiovascular health","volume":"53","author":"Bui","year":"2023","journal-title":"Korean Circ. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvab030","article-title":"Sequence meets function-microbiota and cardiovascular disease","volume":"118","author":"Kim","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41591-022-01686-6","article-title":"Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease","volume":"28","author":"Bar","year":"2022","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Org, E., Blum, Y., Kasela, S., Mehrabian, M., Kuusisto, J., Kangas, A.J., Soininen, P., Wang, Z., Ala-Korpela, M., and Hazen, S.L. (2017). Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol., 18.","DOI":"10.1186\/s13059-017-1194-2"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Chaudhry, U.A.R., Fortescue, R., Bowen, L., Woolford, S.J., Knights, F., Cook, D.G., Harris, T., and Critchley, J. (2025). Comparison of mortality in people with type 2 diabetes between different ethnic groups: Systematic review and meta-analysis of longitudinal studies. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0314318"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/8\/3572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:16Z","timestamp":1760029936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/8\/3572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":114,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["ijms26083572"],"URL":"https:\/\/doi.org\/10.3390\/ijms26083572","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}